Copyright Reports & Markets. All rights reserved.

Global Telmisartan Market Insights, Forecast to 2025

Request for Sample of this report
Buy now

Table of Contents

    1 Telmisartan Market Overview

    • 1.1 Product Overview and Scope of Telmisartan
    • 1.2 Telmisartan Segment by Type
      • 1.2.1 Global Telmisartan Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Injection
      • 1.2.3 Freeze-Dried Powder
    • 1.3 Telmisartan Segment by Application
      • 1.3.1 Telmisartan Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Hospital Use
      • 1.3.3 Clinic Use
      • 1.3.4 Others
    • 1.4 Global Telmisartan Market Size Estimates and Forecasts
      • 1.4.1 Global Telmisartan Revenue 2015-2026
      • 1.4.2 Global Telmisartan Sales 2015-2026
      • 1.4.3 Telmisartan Market Size by Region: 2020 Versus 2026

    2 Global Telmisartan Market Competition by Manufacturers

    • 2.1 Global Telmisartan Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Telmisartan Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Telmisartan Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Telmisartan Manufacturing Sites, Area Served, Product Type
    • 2.5 Telmisartan Market Competitive Situation and Trends
      • 2.5.1 Telmisartan Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Telmisartan Players (Opinion Leaders)

    3 Telmisartan Retrospective Market Scenario by Region

    • 3.1 Global Telmisartan Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Telmisartan Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Telmisartan Market Facts & Figures by Country
      • 3.3.1 North America Telmisartan Sales by Country
      • 3.3.2 North America Telmisartan Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Telmisartan Market Facts & Figures by Country
      • 3.4.1 Europe Telmisartan Sales by Country
      • 3.4.2 Europe Telmisartan Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Telmisartan Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Telmisartan Sales by Region
      • 3.5.2 Asia Pacific Telmisartan Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Telmisartan Market Facts & Figures by Country
      • 3.6.1 Latin America Telmisartan Sales by Country
      • 3.6.2 Latin America Telmisartan Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Telmisartan Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Telmisartan Sales by Country
      • 3.7.2 Middle East and Africa Telmisartan Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Telmisartan Historic Market Analysis by Type

    • 4.1 Global Telmisartan Sales Market Share by Type (2015-2020)
    • 4.2 Global Telmisartan Revenue Market Share by Type (2015-2020)
    • 4.3 Global Telmisartan Price Market Share by Type (2015-2020)
    • 4.4 Global Telmisartan Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Telmisartan Historic Market Analysis by Application

    • 5.1 Global Telmisartan Sales Market Share by Application (2015-2020)
    • 5.2 Global Telmisartan Revenue Market Share by Application (2015-2020)
    • 5.3 Global Telmisartan Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Telmisartan Business

    • 6.1 Pfizer
      • 6.1.1 Corporation Information
      • 6.1.2 Pfizer Description, Business Overview and Total Revenue
      • 6.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Pfizer Products Offered
      • 6.1.5 Pfizer Recent Development
    • 6.2 Teva
      • 6.2.1 Teva Telmisartan Production Sites and Area Served
      • 6.2.2 Teva Description, Business Overview and Total Revenue
      • 6.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Teva Products Offered
      • 6.2.5 Teva Recent Development
    • 6.3 Boehringer Ingelheim
      • 6.3.1 Boehringer Ingelheim Telmisartan Production Sites and Area Served
      • 6.3.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
      • 6.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 Boehringer Ingelheim Products Offered
      • 6.3.5 Boehringer Ingelheim Recent Development
    • 6.4 Novartis
      • 6.4.1 Novartis Telmisartan Production Sites and Area Served
      • 6.4.2 Novartis Description, Business Overview and Total Revenue
      • 6.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Novartis Products Offered
      • 6.4.5 Novartis Recent Development
    • 6.5 Mylan
      • 6.5.1 Mylan Telmisartan Production Sites and Area Served
      • 6.5.2 Mylan Description, Business Overview and Total Revenue
      • 6.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Mylan Products Offered
      • 6.5.5 Mylan Recent Development
    • 6.6 Reddy's Laboratories (UK)
      • 6.6.1 Reddy's Laboratories (UK) Telmisartan Production Sites and Area Served
      • 6.6.2 Reddy's Laboratories (UK) Description, Business Overview and Total Revenue
      • 6.6.3 Reddy's Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Reddy's Laboratories (UK) Products Offered
      • 6.6.5 Reddy's Laboratories (UK) Recent Development
    • 6.7 Hema Pharmaceuticals Pvt
      • 6.6.1 Hema Pharmaceuticals Pvt Telmisartan Production Sites and Area Served
      • 6.6.2 Hema Pharmaceuticals Pvt Description, Business Overview and Total Revenue
      • 6.6.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Hema Pharmaceuticals Pvt Products Offered
      • 6.7.5 Hema Pharmaceuticals Pvt Recent Development
    • 6.8 Bayer
      • 6.8.1 Bayer Telmisartan Production Sites and Area Served
      • 6.8.2 Bayer Description, Business Overview and Total Revenue
      • 6.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Bayer Products Offered
      • 6.8.5 Bayer Recent Development
    • 6.9 GSK
      • 6.9.1 GSK Telmisartan Production Sites and Area Served
      • 6.9.2 GSK Description, Business Overview and Total Revenue
      • 6.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 GSK Products Offered
      • 6.9.5 GSK Recent Development
    • 6.10 Astellas Pharma Inc
      • 6.10.1 Astellas Pharma Inc Telmisartan Production Sites and Area Served
      • 6.10.2 Astellas Pharma Inc Description, Business Overview and Total Revenue
      • 6.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Astellas Pharma Inc Products Offered
      • 6.10.5 Astellas Pharma Inc Recent Development
    • 6.11 Nippon Boehringer Ingelheim
      • 6.11.1 Nippon Boehringer Ingelheim Telmisartan Production Sites and Area Served
      • 6.11.2 Nippon Boehringer Ingelheim Telmisartan Description, Business Overview and Total Revenue
      • 6.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Nippon Boehringer Ingelheim Products Offered
      • 6.11.5 Nippon Boehringer Ingelheim Recent Development
    • 6.12 Abbott
      • 6.12.1 Abbott Telmisartan Production Sites and Area Served
      • 6.12.2 Abbott Telmisartan Description, Business Overview and Total Revenue
      • 6.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.12.4 Abbott Products Offered
      • 6.12.5 Abbott Recent Development
    • 6.13 Takeda
      • 6.13.1 Takeda Telmisartan Production Sites and Area Served
      • 6.13.2 Takeda Telmisartan Description, Business Overview and Total Revenue
      • 6.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.13.4 Takeda Products Offered
      • 6.13.5 Takeda Recent Development
    • 6.14 Beijing Wansheng Pharmaceutical
      • 6.14.1 Beijing Wansheng Pharmaceutical Telmisartan Production Sites and Area Served
      • 6.14.2 Beijing Wansheng Pharmaceutical Telmisartan Description, Business Overview and Total Revenue
      • 6.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2015-2020)
      • 6.14.4 Beijing Wansheng Pharmaceutical Products Offered
      • 6.14.5 Beijing Wansheng Pharmaceutical Recent Development

    7 Telmisartan Manufacturing Cost Analysis

    • 7.1 Telmisartan Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Telmisartan
    • 7.4 Telmisartan Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Telmisartan Distributors List
    • 8.3 Telmisartan Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Telmisartan Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Telmisartan by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Telmisartan by Type (2021-2026)
    • 10.2 Telmisartan Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Telmisartan by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Telmisartan by Application (2021-2026)
    • 10.3 Telmisartan Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Telmisartan by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Telmisartan by Region (2021-2026)
    • 10.4 North America Telmisartan Estimates and Projections (2021-2026)
    • 10.5 Europe Telmisartan Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Telmisartan Estimates and Projections (2021-2026)
    • 10.7 Latin America Telmisartan Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Telmisartan Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Telmisartan market is valued at US$ 3320.7 million in 2020 is expected to reach US$ 3511.9 million by the end of 2026, growing at a CAGR of 0.8% during 2021-2026.
      This report focuses on Telmisartan volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Telmisartan market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Telmisartan market is segmented into
      Injection
      Freeze-Dried Powder

      Segment by Application
      Hospital Use
      Clinic Use
      Others

      Global Telmisartan Market: Regional Analysis
      The Telmisartan market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Telmisartan market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Telmisartan Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Telmisartan market include:
      Pfizer
      Teva
      Boehringer Ingelheim
      Novartis
      Mylan
      Reddy's Laboratories (UK)
      Hema Pharmaceuticals Pvt
      Bayer
      GSK
      Astellas Pharma Inc
      Nippon Boehringer Ingelheim
      Abbott
      Takeda
      Beijing Wansheng Pharmaceutical

      Buy now